These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23592111)

  • 1. JAMA patient page. Aspirin therapy.
    Torpy JM; Livingston EH
    JAMA; 2013 Apr; 309(15):1645. PubMed ID: 23592111
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin for heart attack, stroke prevention. When benefits outweigh risks: four new studies help clarify who should--and who shouldn't--take the drug.
    Duke Med Health News; 2009 Jun; 15(6):3-4. PubMed ID: 19579315
    [No Abstract]   [Full Text] [Related]  

  • 4. Durlaza--a 24-hour extended-release aspirin.
    Med Lett Drugs Ther; 2016 Jan; 58(1486):7. PubMed ID: 26761340
    [No Abstract]   [Full Text] [Related]  

  • 5. Daily aspirin therapy.
    FDA Consum; 2003; 37(5):36. PubMed ID: 14666906
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin for first-line heart attack prevention. These is still no consensus; the benefits must be weighed against the risks.
    Duke Med Health News; 2014 Nov; 20(11):5-6. PubMed ID: 25481928
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin and women--age matters. Aspirin can help healthy women over age 56 prevent both strokes and heart attacks. For younger women, the hazards of aspirin outweigh the benefits.
    Harv Heart Lett; 2005 May; 15(9):1-2. PubMed ID: 15898147
    [No Abstract]   [Full Text] [Related]  

  • 8. Warfarin, aspirin, or both after myocardial infarction.
    Pullicino P; Thompson JL
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12529470
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin or warfarin: what's best after a heart attack? Risk of bleeding counters warfarin's edge in efficacy.
    Ornato JP
    Health News; 2002 Nov; 8(11):3. PubMed ID: 12523247
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin for the prevention of cardiovascular disease.
    Lin KW
    Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
    [No Abstract]   [Full Text] [Related]  

  • 11. Warfarin, aspirin, or both after myocardial infarction.
    Aronow WS
    N Engl J Med; 2003 Jan; 348(3):256-7; author reply 256-7. PubMed ID: 12530434
    [No Abstract]   [Full Text] [Related]  

  • 12. Preventing atherosclerotic events with aspirin.
    Cleland JG
    BMJ; 2002 Jan; 324(7329):103-5. PubMed ID: 11786458
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical practice. Aspirin for primary prevention of coronary events.
    Lauer MS
    N Engl J Med; 2002 May; 346(19):1468-74. PubMed ID: 12000818
    [No Abstract]   [Full Text] [Related]  

  • 14. By the way, doctor. Must I take aspirin?
    Keating N
    Harv Health Lett; 2007 Jul; 32(9):8. PubMed ID: 17663077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin for prevention of myocardial infarction.
    Mirvis DM
    J Tenn Med Assoc; 1995 Oct; 88(10):392-4. PubMed ID: 7475013
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice.
    Prescrire Int; 2009 Dec; 18(104):272-3. PubMed ID: 20027714
    [No Abstract]   [Full Text] [Related]  

  • 17. Is ticlopidine more effective than aspirin in preventing adverse cardiovascular events after myocardial infarction (MI)?
    Olson J; Huntington J
    J Fam Pract; 2001 Jul; 50(7):623. PubMed ID: 11485713
    [No Abstract]   [Full Text] [Related]  

  • 18. Aspirin for the prevention of cardiovascular disease: recommendation statement.
    Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
    [No Abstract]   [Full Text] [Related]  

  • 19. Aspirin after heart attack or stroke.
    Harv Heart Lett; 2013 Apr; 23(8):8. PubMed ID: 23914396
    [No Abstract]   [Full Text] [Related]  

  • 20. Aspirin Monotherapy Should Not Be Recommended for Cardioprotection in Patients With Symptomatic Peripheral Artery Disease.
    Brass EP; Hiatt WR
    Circulation; 2017 Aug; 136(9):785-786. PubMed ID: 28847795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.